Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update: Government Shutdown Ends — What It Means for the Cancer Community As you are no doubt aware, after 43 days, the federal government shutdown officially ended. On November 12, 2025, President Donald J. Trump signed the temporary funding bill passed by Congress, reopening … Continued
New policy hub builds on record of helping to secure billions in federal funding and training thousands of advocates, with expanded priorities and an interactive policy map New York, NY – [November 20, 2025] — Ovarian Cancer Research Alliance (OCRA) today announced the launch of its Center for Public Policy, a dedicated hub that reflects expanded policy … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update As of this writing, Congress has failed to come to an agreement on funding for the current fiscal year and the federal government is in a shutdown. We are closely monitoring the impact that the shutdown is having on the patient community and … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance As fall begins, Congress and state legislatures are facing issues with big implications for health care, research, and patient access. Here’s what’s happening now, and how you can help ensure the ovarian and gynecologic cancer community’s voice is heard. Federal Government Shutdown Upon returning … Continued
OCRA joined more than 400 patient advocates, providers and researchers at the Rally for Medical Research Hill Day on September 18th to call on Congress to increase critical funding at the National Institutes of Health (NIH) for Fiscal Year 2026. Dozens of organizations, including the event’s founding organizer American Association for Cancer Research, met with … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY 2026 Appropriations & Congressional Recess: A Vital Advocacy Window As Congress continues its August recess, this “district and state work period” transforms into a strategic opportunity. Some lawmakers are focused on local engagement like town halls and community meetings, which make it the … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget & Appropriations Update: Approaching August with Focused Advocacy As Congress advances the FY 2026 appropriations process, gynecologic cancer advocates have a key opportunity to engage. The House has delayed its markup of the Labor, Health and Human Services (Labor-HHS) Appropriations bill until after the … Continued
Stop Cuts to Education, Screening & Surveillance Programs The President’s proposed budget for Fiscal Year 2026 would eliminate the CDC’s Division of Cancer Prevention and Control (DCPC). This division supports the only federally funded education and screening programs focused on gynecologic cancers. If these cuts move forward, communities across the country will lose: These programs are … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget Update: Critical Cancer Programs at Risk Congress is deep into its work on the fiscal year 2026 (FY26) appropriations bills, and decisions made now will shape the future of cancer care, prevention, and research. While there is strong bipartisan support for cancer … Continued
FY26 Budget Watch, Advocacy Results, and State-Level Progress As Congress ramps up work on the FY26 federal budget, advocates are focused on maintaining vital cancer programs and advancing state policies that support gynecologic cancer patients. Here’s what’s happened over the last month—and what’s next. Budget Update: CDC Cancer Programs at Risk The administration’s proposed FY26 … Continued
A new article from Patient Power highlights findings from a paper authored by Ovarian Cancer Research Alliance (OCRA) and Komodo Health, that reveals significant gaps in genetic testing for ovarian cancer patients. Chad Ramsey, OCRA’s Vice President of Policy, spoke with Patient Power about the study’s results and the urgent need to close these gaps. … Continued
Spring is here—and so is appropriations season in Washington, DC. This month has brought key developments in both the FY26 federal budget process and state-level policy action that could impact gynecologic cancer research, prevention, and patient care. Here’s what advocates need to know: Draft Budget Proposal Would Eliminate Key CDC Cancer Programs A draft of the administration’s … Continued
Get email updates about research news, action alerts, and ways to join the fight.
